C. B. H. W. Lamers

20.1k total citations · 1 hit paper
518 papers, 15.3k citations indexed

About

C. B. H. W. Lamers is a scholar working on Surgery, Oncology and Gastroenterology. According to data from OpenAlex, C. B. H. W. Lamers has authored 518 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Surgery, 139 papers in Oncology and 111 papers in Gastroenterology. Recurrent topics in C. B. H. W. Lamers's work include Helicobacter pylori-related gastroenterology studies (107 papers), Gastroesophageal reflux and treatments (86 papers) and Neuropeptides and Animal Physiology (69 papers). C. B. H. W. Lamers is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (107 papers), Gastroesophageal reflux and treatments (86 papers) and Neuropeptides and Animal Physiology (69 papers). C. B. H. W. Lamers collaborates with scholars based in Netherlands, United States and Germany. C. B. H. W. Lamers's co-authors include Jan B.�M.�J. Jansen, Hein W. Verspaget, Ad Masclee, Jan W. Gratama, Reno Debets, Stefan Sleijfer, Cornelis F.M. Sier, G Griffioen, Wim P.M. Hopman and I. Biemond and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

C. B. H. W. Lamers

508 papers receiving 14.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity

2013 561 citations C. B. H. W. Lamers, Stefan Sleijfer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. B. H. W. Lamers Netherlands	63	5.0k	4.6k	2.9k	2.8k	2.7k	518	15.3k
Burkhard Göke Germany	72	6.1k 1.2×	4.1k 0.9×	3.6k 1.2×	2.7k 1.0×	6.0k 2.2×	423	20.1k
Tsutomu Chiba Japan	78	8.7k 1.8×	4.5k 1.0×	4.4k 1.5×	4.2k 1.5×	8.0k 3.0×	603	24.2k
Guido Adler Germany	70	4.8k 1.0×	4.4k 1.0×	1.5k 0.5×	2.2k 0.8×	5.1k 1.9×	241	14.1k
Simon C. Robson United States	85	6.4k 1.3×	3.0k 0.7×	3.2k 1.1×	7.0k 2.6×	6.6k 2.5×	473	27.7k
Tooru Shimosegawa Japan	80	13.2k 2.7×	7.0k 1.5×	7.1k 2.4×	3.2k 1.1×	5.3k 2.0×	702	25.7k
Isao Okayasu Japan	51	2.5k 0.5×	3.0k 0.7×	1.6k 0.6×	1.7k 0.6×	4.6k 1.7×	310	11.8k
Takashi Kanematsu Japan	56	4.5k 0.9×	3.1k 0.7×	2.5k 0.8×	845 0.3×	3.4k 1.3×	532	12.8k
Shin Maeda Japan	61	5.4k 1.1×	3.7k 0.8×	3.9k 1.3×	5.1k 1.9×	7.2k 2.7×	463	19.6k
Detlef Schuppan Germany	62	2.8k 0.6×	1.7k 0.4×	4.2k 1.4×	1.3k 0.5×	3.4k 1.3×	278	13.2k
Markus M. Lerch Germany	76	10.9k 2.2×	6.9k 1.5×	3.7k 1.3×	1.6k 0.6×	4.3k 1.6×	448	18.7k

Countries citing papers authored by C. B. H. W. Lamers

Since Specialization

Citations

This map shows the geographic impact of C. B. H. W. Lamers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. B. H. W. Lamers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. B. H. W. Lamers more than expected).

Fields of papers citing papers by C. B. H. W. Lamers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. B. H. W. Lamers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. B. H. W. Lamers. The network helps show where C. B. H. W. Lamers may publish in the future.

Co-authorship network of co-authors of C. B. H. W. Lamers

This figure shows the co-authorship network connecting the top 25 collaborators of C. B. H. W. Lamers. A scholar is included among the top collaborators of C. B. H. W. Lamers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. B. H. W. Lamers. C. B. H. W. Lamers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beusechem, Victor W. van, David P. Noske, C. B. H. W. Lamers, et al.. (2022). Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM:A Phase I Clinical Trial Including Correlative Studies. Digital Commons@Becker (Washington University School of Medicine). 67 indexed citations

Duinhouwer, Lucia, Nick Beije, Bronno van der Holt, et al.. (2018). Impaired thymopoiesis predicts for a high risk of severe infections after reduced intensity conditioning without anti-thymocyte globulin in double umbilical cord blood transplantation. Bone Marrow Transplantation. 53(6). 673–682. 6 indexed citations

Goeje, Pauline L. de, Yarne Klaver, Margaretha E.H. Kaijen-Lambers, et al.. (2018). Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOS. Frontiers in Immunology. 9. 2034–2034. 11 indexed citations

Lamers, C. B. H. W., Rebecca Wijers, Cornelis A.M. van Bergen, et al.. (2016). CD4+ T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation. Blood. 128(17). 2165–2174. 24 indexed citations

Burger, Herman, Peter de Bruijn, C. B. H. W. Lamers, et al.. (2014). Phase I Study of RGB-286638, A Novel, Multitargeted Cyclin-Dependent Kinase Inhibitor in Patients with Solid Tumors. Clinical Cancer Research. 20(18). 4776–4783. 27 indexed citations

Davis, Jeremy L., Marc R. Theoret, Zhili Zheng, et al.. (2010). Development of Human Anti-Murine T-Cell Receptor Antibodies in Both Responding and Nonresponding Patients Enrolled in TCR Gene Therapy Trials. Clinical Cancer Research. 16(23). 5852–5861. 94 indexed citations

Strijbos, Michiel, Claudia A. Snijder, Jaco Kraan, et al.. (2010). Levels of circulating endothelial cells in normotensive and severe preeclamptic pregnancies. Cytometry Part B Clinical Cytometry. 78B(6). 382–386. 9 indexed citations

Strijbos, Michiel, Reno Debets, Jaco Kraan, et al.. (2010). mRNA levels of CD31, CD144, CD146 and von Willebrand factor do not serve as surrogate markers for circulating endothelial cells. Thrombosis and Haemostasis. 104(8). 318–326. 4 indexed citations

Kubben, F J G M, Cornelis F.M. Sier, Lukas J.A.C. Hawinkels, et al.. (2007). Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. European Journal of Cancer. 43(12). 1869–1876. 128 indexed citations

10.

Hawinkels, Lukas J.A.C., Hein W. Verspaget, W. van Duijn, et al.. (2007). Tissue level, activation and cellular localisation of TGF-β1 and association with survival in gastric cancer patients. British Journal of Cancer. 97(3). 398–404. 72 indexed citations

11.

Lamers, C. B. H. W., et al.. (2005). Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancer. Cancer Gene Therapy. 13(5). 503–509. 31 indexed citations

12.

Vantomme, Valérie, Dirk Gheysen, Claudine Bruck, et al.. (2004). Immunologic Analysis of a Phase I/II Study of Vaccination with MAGE-3 Protein Combined with the AS02B Adjuvant in Patients with MAGE-3-Positive Tumors. Journal of Immunotherapy. 27(2). 124–135. 70 indexed citations

13.

Gielkens, H. A. J., W. F. Lam, Minneke J. Coenraad, et al.. (1998). Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans. Journal of Hepatology. 28(4). 595–602. 42 indexed citations

14.

Lamers, C. B. H. W., R. L. H. Bolhuis, Sven O. Warnaar, G. Stoter, & Jan W. Gratama. (1997). Local but no systemic immunomodulation by intraperitoneal treatment of advanced ovarian cancer with autologous T lymphocytes re-targeted by a bi-specific monoclonal antibody. International Journal of Cancer. 73(2). 211–219. 23 indexed citations

15.

Vecht, J. van der, et al.. (1996). Diagnostic Value of Dumping Provocation in Patients after Gastric Surgery. Scandinavian Journal of Gastroenterology. 31(12). 1162–1166. 55 indexed citations

16.

Posthuma, E.F.M., et al.. (1995). Fatal infectious mononucleosis. Gut. 36(2). 1 indexed citations

17.

Arndt, J. W., Hein W. Verspaget, D. Blok, et al.. (1989). Image quality and radiopharmaceutical parameters of Indium-111 granulocytes in scintigraphy of inflammatory bowel disease. European Journal of Nuclear Medicine and Molecular Imaging. 15(4). 197–200. 6 indexed citations

18.

Offerhaus, G. J. A., Paul N.M.A. Rieu, Jan B.�M.�J. Jansen, H. J. M. Joosten, & C. B. H. W. Lamers. (1989). Prospective comparative study of the influence of postoperative bile reflux on gastric mucosal histology and Campylobacter pylori infection.. Gut. 30(11). 1552–1557. 49 indexed citations

19.

Hopman, Wim P.M., Jan B.�M.�J. Jansen, G. Rosenbusch, & C. B. H. W. Lamers. (1986). Gall bladder contraction induced by cholecystokinin: bolus injection or infusion?. BMJ. 292(6517). 375.2–376. 36 indexed citations

20.

Lamers, C. B. H. W., et al.. (1982). Immune response and antigen localization in carp (Cyprinus carpio) after administration of Yersinia ruckeri 0-antigen. Developmental & Comparative Immunology. 2. 107–114. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact